Kezar Life Sciences Inc.
10/22/2025 | Press release | Distributed by Public on 10/22/2025 14:19
Termination of Material Agreement (Form 8-K)
Item 1.02 Termination of a Material Definitive Agreement.
On October 20, 2025, Kezar Life Sciences, Inc. (the "Company"), using cash on hand, made a repayment of $6.3 million in full satisfaction of the aggregate outstanding amount, including accrued interest and exit fees as of such date, under the Loan and Security Agreement (the "Loan Agreement"), dated as of November 4, 2021, among the Company, as borrower, Oxford Finance LLC, as collateral agent, and the lenders party thereto. The Loan Agreement was terminated in accordance with the terms of a payoff letter and all liens and security interests granted thereunder to secure the obligations were released.
Kezar Life Sciences Inc. published this content on October 22, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on October 22, 2025 at 20:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]